ROME — At OSN Italy, Rolando Toyos, MD, discusses the recent FDA approval of intense pulsed light treatment for dry eye due to meibomian gland dysfunction with the OptiLight system from Lumenis.
Toyos developed and perfected this technology over 20 years and speaks here about the results of the study that led to approval.